EP 1037883 A1 20000927 - NOVEL HETEROCYCLICALLY SUBSTITUTED $g(a)-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
Title (en)
NOVEL HETEROCYCLICALLY SUBSTITUTED $g(a)-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
Title (de)
NEUE HETEROCYCLISCH SUBSTITUIERTE $g(a)-HYDROXYCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELINREZEPTORANTAGONISTEN
Title (fr)
NOUVEAUX DERIVES D'ACIDE $g(a)-HYDROXYCARBOXYLIQUE HETEROCYCLIQUEMENT SUBSTITUES, LEUR PRODUCTION ET LEUR UTILISATION COMME ANTAGONISTES DU RECEPTEUR DE L'ENDOTHELINE
Publication
Application
Priority
- DE 19750529 A 19971114
- EP 9807026 W 19981104
Abstract (en)
[origin: US6358983B1] The present invention relates to carboxylic acid derivatives of the formula Ithe substituents having the meanings explained in the description, preparation and use as endothelin receptor antagonists.
IPC 1-7
C07D 277/34; C07D 263/38; A61K 31/425; A61K 31/42; C07D 277/60; C07D 277/68
IPC 8 full level
C07D 249/12 (2006.01); A61K 31/41 (2006.01); A61K 31/415 (2006.01); A61K 31/4164 (2006.01); A61K 31/42 (2006.01); A61K 31/421 (2006.01); A61K 31/422 (2006.01); A61K 31/4245 (2006.01); A61K 31/425 (2006.01); A61K 31/426 (2006.01); A61K 31/427 (2006.01); A61K 31/428 (2006.01); A61K 31/433 (2006.01); A61P 9/04 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 11/06 (2006.01); A61P 13/08 (2006.01); A61P 13/12 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 231/20 (2006.01); C07D 233/70 (2006.01); C07D 261/12 (2006.01); C07D 263/38 (2006.01); C07D 271/06 (2006.01); C07D 271/10 (2006.01); C07D 273/01 (2006.01); C07D 275/02 (2006.01); C07D 275/03 (2006.01); C07D 277/20 (2006.01); C07D 277/32 (2006.01); C07D 277/34 (2006.01); C07D 277/60 (2006.01); C07D 277/68 (2006.01); C07D 285/00 (2006.01); C07D 285/08 (2006.01); C07D 285/12 (2006.01); C07D 291/04 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01)
CPC (source: EP US)
A61P 9/00 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 13/08 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 261/12 (2013.01 - EP US); C07D 263/38 (2013.01 - EP US); C07D 275/03 (2013.01 - EP US); C07D 277/34 (2013.01 - EP US); C07D 277/60 (2013.01 - EP US); C07D 277/68 (2013.01 - EP US)
Citation (search report)
See references of WO 9925701A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
US 6358983 B1 20020319; AR 017581 A1 20010912; AU 1487899 A 19990607; AU 752165 B2 20020905; BG 104400 A 20010131; BR 9814157 A 20001003; CA 2308746 A1 19990527; CN 1278805 A 20010103; CO 4990973 A1 20001226; DE 19750529 A1 19990520; EP 1037883 A1 20000927; HR P980591 A2 19990831; HU P0004341 A1 20011028; HU P0004341 A3 20011228; ID 24819 A 20000824; IL 135461 A0 20010520; JP 2001523671 A 20011127; KR 20010032083 A 20010416; NO 20002154 D0 20000427; NO 20002154 L 20000512; NZ 504289 A 20020301; PL 340756 A1 20010226; SK 4932000 A3 20010212; TR 200001365 T2 20000921; WO 9925701 A1 19990527; ZA 9810425 B 20000515
DOCDB simple family (application)
US 53038200 A 20000427; AR P980105651 A 19981109; AU 1487899 A 19981104; BG 10440000 A 20000504; BR 9814157 A 19981104; CA 2308746 A 19981104; CN 98811085 A 19981104; CO 98067231 A 19981113; DE 19750529 A 19971114; EP 9807026 W 19981104; EP 98958900 A 19981104; HR P980591 A 19981113; HU P0004341 A 19981104; ID 20000882 A 19981104; IL 13546198 A 19981104; JP 2000521084 A 19981104; KR 20007005207 A 20000513; NO 20002154 A 20000427; NZ 50428998 A 19981104; PL 34075698 A 19981104; SK 4932000 A 19981104; TR 200001365 T 19981104; ZA 9810425 A 19981113